CHRISTINE STEIMER: Open Payments
NPI 1396110326 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$854 in 42 payments from 9 companies in 2025. Trend: 2023 $2,098 · 2024 $587 · 2025 $854
Food & beverage: $854
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 4 | $241 |
| Boston Scientific Corporation | 15 | $187 |
| Collegium Pharmaceutical, Inc. | 11 | $137 |
| PROTEGA PHARMACEUTIALS INC | 3 | $106 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 5 | $92 |
| Saluda Medical Americas, Inc. | 1 | $29 |
| Abbott Laboratories | 1 | $27 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $19 |
| ABBVIE INC. | 1 | $15 |
Products named: INTELLIS ADAPTIVESTIM, ROXYBOND, WaveWriter Alpha Prime 16, XTAMPZA, RELISTOR, General - Pain Management, SYNCHROMEDII, Belbuca.
Industry payments across AZ — which companies pay providers there.
